2021-01-04,b'RT @Tickeron: $XNCR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/0PHPBnNeOk #Xe\xe2\x80\xa6'
2021-01-04,b'$XNCR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/0PHPBnNeOk #Xencor #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/qvTVttGGSw'
2021-01-04,b'Sold $XNCR and $EW for both break even. \n\nShort term caution!'
2021-01-03,b'$IGPK Will Announce Terms Of Agreement Reached in Significant Partnership Deal With Nasdaq Traded Company\nhttps://t.co/Mv3xmUJu9A\n\n$AAGC $XPLT $XPL $XPER $XNCR $XLRN $XIN $XHUA $CCRC $CCOP $CCMP $CBZ $CBU $CBRL'
2021-01-02,b'RT @LONGADAP: $ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNV\xe2\x80\xa6'
2021-01-01,b'$XNCR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/HVlp02uPWB #Xencor #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TBt8GZQgnr'
2021-01-01,"b""$XNCR:\n\nNew Insider Filing on Xencor Inc's\n\nSR. VICE PRESIDENT &amp; CFO\n\nJOHN J KUCH:\n\nhttps://t.co/MkbhSRRnw8"""
2020-12-31,"b'$XNCR Xencor, Inc. SEC Filing: Form 4 https://t.co/npwHMuGGDE'"
2020-12-31,"b'Kuch John J (SR. VICE PRESIDENT &amp; CFO) sold new securities, reported in a new form 4 filed with the SEC  $XNCR https://t.co/5KJV6kF3Pb'"
2020-12-31,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/iddZiroZqJ'
2020-12-31,"b'@IBD_AGatlin @menosave $ions will have a dozen trial updates at min, many unpartnered. $CRSP $EDIT $NTLA $ARKK $AMGN $GMAB $XNCR $MGNX $RHHBY $SGEN $GILD $IMGN $MRSN $ZYME $STRO $ARWR $PFE $BNTX $MRNA $TBIO $ARCT $ILMN $EXAS $GH $biib $azn $pfe $mrna $NTRA $arkg $alny @ARKInvest @CathieDWood @Fidelity'"
2020-12-31,b'$MGM Will Announce Terms Of Agreement Reached in Significant Partnership Deal With Nasdaq Traded Company\nhttps://t.co/Mv3xmUJu9A\n\n$AAGC $XPLT $XPL $XPER $XNCR $XLRN $XIN $XHUA $CCRC $CCOP $CCMP $CBZ $CBU $CBRL'
2020-12-30,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/CNWtsWmqa0'
2020-12-30,"b""Here's why you shouldn't expect the #biotech stock fervor to end in 2021. $CRSP $EDIT $NTLA $ARKK $AMGN $GMAB $XNCR $MGNX $RHHBY $SGEN $GILD $IMGN $MRSN $ZYME $STRO $PFE $BNTX $MRNA $TBIO $ARCT $ILMN $EXAS $GH $NTRA #feature #stocks https://t.co/PcdUYWyRw0"""
2020-12-29,b'Stopped out of $QS (+2.78R) $XNCR (-0.23R) $CRSP (+2R) $GNRC (+1.5R) $FATE (-0.05R) $EMR (-0.59R) $WD (+0.26R)'
2020-12-28,b'RT @HackermanAce: Added to my $xncr position and to my $aapl calls'
2020-12-28,b'Added to my $xncr position and to my $aapl calls'
2020-12-28,"b'RT @TomSilver39: Barclays:"" SCENARIO ANALYSIS OF M&amp;A VALUATIONS FOR Barclays COVERAGE: $KPTI, $EPZM, $EXEL, $AGIO, $RCUS, $DCPH, $CTMX, $NK\xe2\x80\xa6'"
2020-12-28,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/1eDxx2aPXB'
2020-12-28,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/WUuJUKPokF'
2020-12-27,"b'$OPTI to advance reverse split option to reluctant investors, announcement coming\nhttps://t.co/aQqxh927Rv\n\n$ALKM $GOHE $TWTR $MJTK $HAON $T $AAGC $XPLT $XPL $XPER $XNCR $XLRN'"
2021-01-08,b'Stocks/ETFs that traded to new 52 week highs/lows this session: $TROW $TRS $TSLA $TTGT $TTWO $TUP $TVTX $TWST $TXN $UIS $UNP $VC $VCEL $VECO $VICR $VMC $VNTR $VRNT $VSTO $VVV $WAB $WAL $WAT $WK $WMS $WSC $WST $X $XNCR $XPER $XYL $Z $ZBRA $ZEN $ZUMZ'
2021-01-08,b'$xncr good so far but really want the rip and the weak zone to pass asap. https://t.co/0MssPUoPxe https://t.co/QP61iQbpdb'
2021-01-08,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/yqdCHqbo6U'
2021-01-08,b'$ONCS $10 PT Dawson James\xf0\x9f\x9a\x80\n\n$CVAC $BNTX $ALNY $EBS $VIR $ADPT $ARCT $TBIO $VXRT $ATRA $VBIV $ALT $DVAX $IBIO $HTBX $TNXP $NNVC $PDSB $TFX $GOVX $IGC $MACK $MRUS $XNCR $FPRX $INCY $AGIO $GBT $HALO $ALKS $KPTI $CARA $ZGNX $TMO $EW $DXCM $IDXX $NVTA $HZNP $BMRN $VRTX $ABT $MDT $BSX https://t.co/s09ynVi8IA'
2021-01-08,"b'$XNCR Xencor, Inc. - Common Sto Top stock up 135% from low. Close: 48.67 VolvsAvg: 1.21 Liq: $13M https://t.co/Vf6pmb1PZm'"
2021-01-08,b'$XNCR  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 171'
2021-01-08,b'An Altman-Z score of 21.42 indicates that $XNCR is not in any danger for bankruptcy at the moment. https://t.co/TBGnTvoeZc https://t.co/sLE1fXSTPn'
2021-01-08,b'All time high $XNCR and looking strong! https://t.co/7Dw9in33R0'
2021-01-08,"b'$XNCR enters an Uptrend because Momentum Indicator exceeded the 0 level on January 6, 2021. View odds for this and other indicators: https://t.co/l7IT1neQCG #Xencor #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IA4va7IUYa'"
2021-01-07,b'2/2 Biotech/HC New or revisited 52-Week Highs:  $PLSE $CDMO $PRAH $PRPH $PTCT $IQV $RDUS $SAGE $SEM $SGRY $SLDB $SKLN $STE $TECH $UTHR $VBLT $VCEL $VTGN $WCG $XNCR $SPY $QQQ'
2021-01-07,"b'Next generation biotech platform leader:\n\n5)New Cell therapy: $FATE, $ALLO, $ALLO, $AFMD, $TCRR\n6)Antibody engineering: $SGEN, $RGEN, $GMAB,$YMAB, $ARGX $ZYME, $BCYC, $XNCR, $MGNX\n7) Kinase Inhibitor: $MRTX, $TPTX, $DCPH, $RLAY, $PRLD; $RVMD; $BDTX; $PMVP;$SDGR'"
2021-01-07,"b'$XNCR Xencor, Inc. - Common Sto Top stock up 130% from low. Close: 46.36 VolvsAvg: 1.50 Liq: $15M https://t.co/Vf6pmb1PZm'"
2021-01-07,b'$XNCR - Xencor (XNCR) Inks Deal for Novel Antibody Therapies in Cancer https://t.co/5iNN9KNfZe https://t.co/HiG2YCG8C5'
2021-01-07,"b""The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration $IBB $XNCR $ADXN https://t.co/apieRZyZNh via @benzinga"""
2021-01-07,b'#Xencor and #MDAnderson Enter Strategic Collaboration to Develop Novel #TCell Engaging #Bispecific #Antibodies for Potential Treatment of Patients with #Cancer $XNCR https://t.co/61UKnH5tnq'
2021-01-07,b'$XNCR MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients https://t.co/0s6F0AeC0K'
2021-01-07,"b""The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration $IBB $XNCR $ADXN https://t.co/YPzZFRQDkF via @benzinga"""
2021-01-07,b'RT @JBMGStockTrades: Another one for long term for you biotech junkies\n$XNCR this company develops antibodies to fight cancer. Its breaking\xe2\x80\xa6'
2021-01-07,b'Another one for long term for you biotech junkies\n$XNCR this company develops antibodies to fight cancer. Its breaking a 3 year consolidation.\n$47 buy with $42.4 stop and a $75 target. big time risk to reward https://t.co/G6zqQg3SAv'
2021-01-07,"b'ticker symbol $XNCR Xencor, MD Anderson ink development pact for CD3 bispecific antibody for cancer https://t.co/WAZweZKXcB #premarket #stockmarket #news #cancer'"
2021-01-07,b'$XNCR Xencor and MD Anderson Enter Strategic Collaboration to Develop Novel T Cell-Engaging Bispecific Antibodies for Potential Treatment of Patients with Cancer https://t.co/ziBD3ggofn'
2021-01-07,"b'RT @chaperonycon: $xncr and MD Anderson collaboration means big beneficial deal. Target finding by MD Anderson, preclinical financing, XMAB\xe2\x80\xa6'"
2021-01-07,"b'$xncr and MD Anderson collaboration means big beneficial deal. Target finding by MD Anderson, preclinical financing, XMAB-technology by #xencor and choice of worldwide licensing.\nhttps://t.co/aGaGnfzqBe'"
